SCHEMBL17297802

SCHEMBL17297802

CCn1c(C)cc(=O)c(CNC(=O)C(C)(C)C)c1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ PTGES O14684 3/20 0.36
▸ POLB P06746 1/20 0.35
▸ P2RX7 Q99572 3/20 0.34
▸ HTT P42858 1/20 0.34
▸ DRD4 P21917 3/20 0.33
▸ DRD2 P14416 2/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17297977 0.85 KDM4E (0.38) KDM4ETP53POLBP2RX7RAB9A
SCHEMBL17297803 0.84 MAPT (0.39) KDM4ETP53PTGESP2RX7HTT
SCHEMBL17297819 0.74 MAPT (0.37) KDM4ETP53P2RX7DRD4DRD2
SCHEMBL17297818 0.72 MAPT (0.38) KDM4ETP53P2RX7DRD4DRD2
SCHEMBL17297835 0.71 KDM4E (0.39) KDM4ETP53PTGESP2RX7HTT
SCHEMBL17297854 0.71 DRD4 (0.36) P2RX7DRD4DRD2HDAC6CA1
SCHEMBL17297804 0.69 TP53 (0.35) KDM4ETP53P2RX7DRD4DRD2
SCHEMBL17297870 0.68 KDM4E (0.34) KDM4ETP53P2RX7DRD4DRD2
SCHEMBL17297921 0.68 CYP1A2 (0.40) KDM4ETP53POLBP2RX7ALDH1A1
SCHEMBL17297837 0.68 KDM4E (0.38) KDM4ETP53PTGESPOLBP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134692-A1 1,4-PYRIDONE BICYCLIC HETEROARYL COMPOUNDS Epizyme, Inc. 2018-05-17 — — US disclosed
US-9701666-B2 1,4-pyridone bicyclic heteroaryl compounds Epizyme, Inc. (US) 2017-07-11 — — US disclosed
US-9701666-B2 1,4-pyridone bicyclic heteroaryl compounds Epizyme, Inc. (US) 2017-07-11 — — US disclosed
US-20150344459-A1 1,4-PYRIDONE BICYCLIC HETEROARYL COMPOUNDS Epizyme, Inc. 2015-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344459-A1 1,4-PYRIDONE BICYCLIC HETEROARYL COMPOUNDS CYP4B1, PDXK, CYP1B1 KDM4E 821/4885TP53 350/4885PTGES 700/4885
US-20180134692-A1 1,4-PYRIDONE BICYCLIC HETEROARYL COMPOUNDS CYP4B1, PDXK, CYP1B1 KDM4E 821/4885TP53 350/4885PTGES 700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback